• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用抗菌肽LL-37对抗唾液中SARS-CoV-2病毒载量的潜力:一项计算机模拟分析。

Utilizing the Potential of Antimicrobial Peptide LL-37 for Combating SARS-COV- 2 Viral Load in Saliva: an In Silico Analysis.

作者信息

Nireeksha Nireeksha, Gollapalli Pavan, Varma Sudhir Rama, Hegde Mithra N, Kumari N Suchetha

机构信息

Department of Conservative Dentistry and Endodontics, AB Shetty Memorial Institute of Dental Sciences, NITTE (deemed to be) University, Deralakatte, Mangaluru, Karnataka, India.

Central Research Laboratory, K.S. Hegde Medical Academy, NITTE (deemed to be) University, Deralakatte, Mangaluru, Karnataka, India.

出版信息

Eur J Dent. 2022 Jul;16(3):478-487. doi: 10.1055/s-0041-1739444. Epub 2021 Dec 22.

DOI:10.1055/s-0041-1739444
PMID:34937110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9507610/
Abstract

Limiting the spread of virus during the recent pandemic outbreak was a major challenge. Viral loads in saliva, nasopharyngeal and oropharyngeal swabs were the major cause for droplet transmission and aerosols. Saliva being the major contributor for the presence of viral load is the major key factor; various mouthwashes and their combination were analyzed and utilized in health care centers to hamper the spread of virus and decrease viral load. The compositions of these mouthwashes to an extent affected the viral load and thereby transmission, but there is always a scope for other protocols which may provide better results. Here we evaluated the potential of antimicrobial peptide LL-37 in decreasing the viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through an work and evidence from other studies. This narrative review highlighted a brief nonsystematic methodology to include the selected articles for discussion. Accessible electronic databases (Medline, Scopus, Web of Science, SciELO, and PubMed) were used to find studies that reported the salivary viral load of SARS-CoV-2 published between December 2019 and June 2021. The following keywords were utilized for brief searching of the databases: "saliva," "viral load," and "SARS-CoV-2." Articles in English language, cell-line studies, studies, and clinical trials explaining the viral load of SARS-CoV-2 in saliva and strategies to decrease viral load were included in this review. The search was complemented by manual searching of the reference lists of included articles and performing a citation search for any additional reviews. The antiviral potential of cationic host defense peptide LL-37 was evaluated using computational approaches providing evidence. The analysis of docking studies and the display of positive interfacial hydrophobicity of LL-37 resulting in disruption of COVID-19 viral membrane elucidate the fact that LL-37 could be effective against all variants of SARS-CoV-2. Further experimental studies would be needed to confirm the binding of the receptor-binding domain with LL-37. The possibility of using it in many forms further to decrease the viral load by disrupting the viral membrane is seen.

摘要

在最近的疫情爆发期间,限制病毒传播是一项重大挑战。唾液、鼻咽拭子和口咽拭子中的病毒载量是飞沫传播和气溶胶的主要原因。唾液是病毒载量存在的主要贡献者,是主要关键因素;各种漱口水及其组合在医疗保健中心进行了分析和应用,以阻碍病毒传播并降低病毒载量。这些漱口水的成分在一定程度上影响了病毒载量,进而影响传播,但总是有其他方案可能会提供更好结果的空间。在此,我们通过一项工作以及其他研究的证据,评估了抗菌肽LL-37降低严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒载量的潜力。这篇叙述性综述强调了一种简要的非系统性方法,以纳入选定的文章进行讨论。使用可访问的电子数据库(Medline、Scopus、科学引文索引、SciELO和PubMed)来查找报告2019年12月至2021年6月期间SARS-CoV-2唾液病毒载量的研究。以下关键词用于对数据库进行简要搜索:“唾液”、“病毒载量”和“SARS-CoV-2”。本综述纳入了用英语撰写的文章、细胞系研究、解释唾液中SARS-CoV-2病毒载量的研究以及降低病毒载量的策略的临床试验。通过人工搜索纳入文章的参考文献列表并对任何其他综述进行引文搜索来补充搜索。使用计算方法评估阳离子宿主防御肽LL-37的抗病毒潜力,提供了证据。对接研究分析以及LL-37的正界面疏水性显示导致新冠病毒膜破裂,阐明了LL-37可有效对抗SARS-CoV-2所有变体这一事实。还需要进一步的实验研究来确认受体结合域与LL-37的结合。可以看到以多种形式使用它来通过破坏病毒膜进一步降低病毒载量的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5c/9507610/b7ec2292fece/10-1055-s-0041-1739444-i2171681-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5c/9507610/9127989fa390/10-1055-s-0041-1739444-i2171681-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5c/9507610/b7ec2292fece/10-1055-s-0041-1739444-i2171681-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5c/9507610/9127989fa390/10-1055-s-0041-1739444-i2171681-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5c/9507610/b7ec2292fece/10-1055-s-0041-1739444-i2171681-2.jpg

相似文献

1
Utilizing the Potential of Antimicrobial Peptide LL-37 for Combating SARS-COV- 2 Viral Load in Saliva: an In Silico Analysis.利用抗菌肽LL-37对抗唾液中SARS-CoV-2病毒载量的潜力:一项计算机模拟分析。
Eur J Dent. 2022 Jul;16(3):478-487. doi: 10.1055/s-0041-1739444. Epub 2021 Dec 22.
2
Is chlorhexidine mouthwash effective in lowering COVID-19 viral load? A systematic review.洗必泰含漱液在降低 COVID-19 病毒载量方面是否有效?一项系统评价。
Eur Rev Med Pharmacol Sci. 2023 Jan;27(1):366-377. doi: 10.26355/eurrev_202301_30890.
3
Comparing SARS-CoV-2 Viral Load in Human Saliva to Oropharyngeal Swabs, Nasopharyngeal Swabs, and Sputum: A Systematic Review and Meta-Analysis.比较人类唾液与口咽拭子、鼻咽拭子和痰液中SARS-CoV-2病毒载量:一项系统评价和荟萃分析。
Can J Infect Dis Med Microbiol. 2023 Aug 10;2023:5807370. doi: 10.1155/2023/5807370. eCollection 2023.
4
The efficacy of mouthwashes in reducing SARS-CoV-2 viral loads in human saliva: A systematic review.漱口水对降低人类唾液中SARS-CoV-2病毒载量的疗效:一项系统评价。
New Microbes New Infect. 2022 Nov-Dec;49:101064. doi: 10.1016/j.nmni.2022.101064. Epub 2022 Dec 12.
5
The effect of mouthrinses on severe acute respiratory syndrome coronavirus 2 viral load: A systematic review.含漱剂对严重急性呼吸综合征冠状病毒 2 病毒载量的影响:系统评价。
J Am Dent Assoc. 2022 Jul;153(7):635-648.e16. doi: 10.1016/j.adaj.2021.12.007. Epub 2021 Dec 30.
6
Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot study.三种抗菌漱口液对降低住院患者唾液中 SARS-CoV-2 病毒载量的疗效:一项随机对照的初步研究。
Sci Rep. 2023 Aug 4;13(1):12647. doi: 10.1038/s41598-023-39308-x.
7
SARS-CoV-2 Presence in the Saliva, Tears, and Cerumen of COVID-19 Patients.SARS-CoV-2 在 COVID-19 患者的唾液、泪液和耳垢中的存在。
Laryngoscope. 2021 May;131(5):E1677-E1682. doi: 10.1002/lary.29218. Epub 2020 Nov 19.
8
Could certain mouthwashes reduce transmissibility of COVID-19?某些漱口水能否降低 COVID-19 的传播性?
Evid Based Dent. 2021 Jan;22(2):82-83. doi: 10.1038/s41432-021-0172-4.
9
Efficacy of Pre-Procedural Mouthwashes against SARS-CoV-2: A Systematic Review of Randomized Controlled Trials.术前漱口水对严重急性呼吸综合征冠状病毒2的疗效:随机对照试验的系统评价
J Clin Med. 2022 Mar 18;11(6):1692. doi: 10.3390/jcm11061692.
10
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.

引用本文的文献

1
Epithelial Antimicrobial Peptide/Protein and Cytokine Expression Profiles Obtained from Nasopharyngeal Swabs of SARS-CoV-2-Infected and Non-Infected Subjects.从 SARS-CoV-2 感染和未感染患者的鼻咽拭子中获得的上皮抗菌肽/蛋白和细胞因子表达谱。
Viruses. 2024 Sep 15;16(9):1471. doi: 10.3390/v16091471.
2
Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation.抗菌肽 cathelicidin 在血栓形成和血栓炎症中的作用。
Front Immunol. 2023 Apr 5;14:1151926. doi: 10.3389/fimmu.2023.1151926. eCollection 2023.

本文引用的文献

1
Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial.使用漱口水降低唾液中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)载量:一项随机试点临床试验。
Heliyon. 2021 Jun;7(6):e07346. doi: 10.1016/j.heliyon.2021.e07346. Epub 2021 Jun 18.
2
Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial.使用抗病毒漱口水作为无症状至轻度 COVID-19 成人 SARS-CoV-2 传播的屏障措施:一项多中心、随机、双盲对照试验。
Clin Microbiol Infect. 2021 Oct;27(10):1494-1501. doi: 10.1016/j.cmi.2021.05.028. Epub 2021 May 24.
3
SARS-CoV-2 infection of the oral cavity and saliva.
SARS-CoV-2 对口腔和唾液的感染。
Nat Med. 2021 May;27(5):892-903. doi: 10.1038/s41591-021-01296-8. Epub 2021 Mar 25.
4
Disinfectants Used in Stomatology and SARS-CoV-2 Infection.口腔医学中使用的消毒剂与新型冠状病毒 2019 感染
Eur J Dent. 2021 May;15(2):388-400. doi: 10.1055/s-0041-1724154. Epub 2021 Mar 10.
5
Virucidal activity of oral care products against SARS-CoV-2 .口腔护理产品对新型冠状病毒的杀病毒活性
J Oral Maxillofac Surg Med Pathol. 2021 Jul;33(4):475-477. doi: 10.1016/j.ajoms.2021.02.002. Epub 2021 Feb 22.
6
Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.商用漱口水对唾液中SARS-CoV-2病毒载量的疗效:新加坡的随机对照试验
Infection. 2021 Apr;49(2):305-311. doi: 10.1007/s15010-020-01563-9. Epub 2020 Dec 14.
7
Dental Office Prevention of Coronavirus Infection.牙科诊所预防冠状病毒感染。
Eur J Dent. 2020 Dec;14(S 01):S146-S151. doi: 10.1055/s-0040-1715923. Epub 2020 Dec 7.
8
COVID-19 Pandemic: Oral Health Challenges and Recommendations.COVID-19大流行:口腔健康挑战与建议。
Eur J Dent. 2020 Dec;14(S 01):S165-S170. doi: 10.1055/s-0040-1718641. Epub 2020 Nov 24.
9
SARS-CoV-2 and Dentistry-Review.严重急性呼吸综合征冠状病毒2与牙科——综述
Eur J Dent. 2020 Dec;14(S 01):S130-S139. doi: 10.1055/s-0040-1716438. Epub 2020 Sep 15.
10
Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections.抗菌肽LL-37在自身免疫性疾病和病毒感染中的免疫调节作用
Vaccines (Basel). 2020 Sep 10;8(3):517. doi: 10.3390/vaccines8030517.